United States· US:60505-2671_68d09be6-1a04-4117-85dc-1d975e475c6a
ATORVASTATIN CALCIUM
A medicinal product containing atorvastatin calcium propylene glycol solvate, registered in United States by Apotex Corp..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE
- Manufacturer
- Apotex Corp.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1160505-2671-0
- ndc1160505-2671-3
- ndc1160505-2671-5
- ndc1160505-2671-7
- ndc1160505-2671-8
- ndc1160505-2671-9
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d20c556e-5d3a-4695-93ee-45a93c1834ce GET /v1/drugs/d20c556e-5d3a-4695-93ee-45a93c1834ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "80",
"substance": "ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE",
"productndc": "60505-2671",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA090548",
"marketing_category": "ANDA"
}See everything about atorvastatin calcium propylene glycol solvate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.